The Company and Embecta entered into various agreements to effect the spin-off and provide a framework for the relationship between the Company and Embecta after the spin-off. Such agreements include the separation and distribution agreement, as well as the following ongoing agreements: a cannula supply agreement, an intellectual property matters agreement, a transition services agreement, manufacturing and 64 Table of Contents Notes to Consolidated Financial Statements — (Continued) Becton, Dickinson and C ...

Becton, Dickinson and Company (NYSE:BDX) Q43 2023 Earnings Conference Call November 9, 2023 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer and Head of Investor Relations Tom Polen – Chairman, President and Chief Executive Officer Chris DelOrefice – Executive Vice President and Chief Financial Officer Conference Call Participants Robbie Marcus - JPMorgan Vijay Kumar - Evercore ISI Larry Biegelsen - Wells Fargo Travis Steed - Bank of America Matt Miksic - Barclays Operator Hel ...

Becton, Dickinson and Company (NYSE:BDX) Q3 2023 Earnings Conference Call August 3, 2023 8:00 AM ET Company Participants Francesca DeMartino – Senior Vice President-Investor Relations Tom Polen – Chairman, President and Chief Executive Officer Chris DelOrefice – Executive Vice President and Chief Financial Officer Mike Garrison – President-Medical Segment Dave Hickey – President-Life Sciences Segment Conference Call Participants Vijay Kumar – Evercore ISI Larry Biegelsen – Wells Fargo Robbie Marcus – JPMorg ...

| --- | --- | --- | |----------------------------------------------|-----------|-------------------------| | | | | | | | | | Q3 FY23 Earnings Presentation August 3, 2023 | | | | | | | | | Advancing | the world of health TM | Caution Concerning Forward-Looking Statements This presentation and accompanying audio webcast contain certain estimates and other forward-looking statements (as defined under federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-4802 Becton, Dickinson and Company (Exact name of registrant as specified in its charter) 1 Becton Drive, Franklin Lakes, New Jersey 07417-1880 (201) 847-6800 (Address of principal executive offices) (Zip Code) (Registrant's telephone number, including area code) Indica ...

| --- | --- | |-------------------------------------------|-------------------------------------| | | | | | | | Q2 FY23 Earnings Presentation May 4, 2023 | | | | Advancing the world of health TM | Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, earnings per share, leverage targets a ...

Becton, Dickinson and Company (NYSE:BDX) Q2 2023 Earnings Conference Call May 4, 2023 8:00 AM ET Company Participants Francesca DeMartino - Senior Vice President and Head-Investor Relations Tom Polen - Chairman, Chief Executive Officer and President Chris DelOrefice - Executive Vice President and Chief Financial Officer Mike Garrison - President-Medical Segment Rick Byrd - President of the Interventional segment Dave Hickey - President-Life Sciences Segment Conference Call Participants Robbie Marcus - JPMor ...

Cash flows from continuing operating activities in the first six months of fiscal year 2023 reflected net income, adjusted by a change in operating assets and liabilities that was a net use of cash. This net use of cash primarily reflected lower levels of accounts payable and accrued expenses, as well as higher levels of inventory and trade receivables. Cash flows from continuing operating activities in the first six months of fiscal year 2022 reflected net income, adjusted by a change in operating assets a ...

TD Cowen 43rd Annual Health Care Conference March 6, 2023 Tom Polen Chairman, CEO, and President Caution Concerning Forward-Looking Statements This presentation contains certain estimates and other forward-looking statements (as defined under federal securities laws) regarding BD's future prospects and performance, including, but not limited to, future revenues, margins, earnings per share, leverage targets and capital deployment. All such statements are based upon current expectations of BD and involve a n ...

Becton, Dickinson and Company (NYSE:BDX) Q1 2023 Earnings Conference Call February 2, 2023 8:00 AM ET Company Participants Francesca DeMartino – Senior Vice President and Head-Investor Relations Tom Polen – Chairman, Chief Executive Officer and President Chris DelOrefice – Executive Vice President and Chief Financial Officer Dave Hickey – President-Life Sciences Segment Mike Garrison – President-Medical Segment Conference Call Participants Vijay Kumar – Evercore ISI Matt Taylor – Jefferies Larry Biegelsen – ...